ERG and prostate cancer: In prostate cancer tissues, Tomlins et al in 2005 identified recurrent gene fusions at the TMPRSS2 5′ UTR (untranslated region) to ETV1 or ERG with an outlier expression that drives cancer progression, suggesting oncogenic roles in prostate cancer.2